Marta López‐Parra

2.4k total citations
22 papers, 1.8k citations indexed

About

Marta López‐Parra is a scholar working on Epidemiology, Biochemistry and Hepatology. According to data from OpenAlex, Marta López‐Parra has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Biochemistry and 9 papers in Hepatology. Recurrent topics in Marta López‐Parra's work include Liver Disease Diagnosis and Treatment (9 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Inflammatory mediators and NSAID effects (7 papers). Marta López‐Parra is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Inflammatory mediators and NSAID effects (7 papers). Marta López‐Parra collaborates with scholars based in Spain, United States and Poland. Marta López‐Parra's co-authors include Joan Clària, Vicente Arroyo, Esther Titos, Ana González‐Périz, Marcos Martínez‐Clemente, Raquel Horrillo, Eva Morán‐Salvador, Natàlia Ferré, Anna Planagumà and Karsten Gronert and has published in prestigious journals such as The Journal of Immunology, Hepatology and The FASEB Journal.

In The Last Decade

Marta López‐Parra

22 papers receiving 1.8k citations

Peers

Marta López‐Parra

EPIDE

BIOCH

PHYSI

Eva Morán‐Salvador Spain

Ana González‐Périz Spain

Marcos Martínez‐Clemente Spain

Raquel Horrillo Spain

Cristina López‐Vicario Spain

Verónica García‐Alonso Spain

Gladys Tapia Chile

Anna Planagumà Spain

Fatiha Nassir United States

Shinzo Kato Japan

Eva Morán‐Salvador Spain

Marta López‐Parra

968 ×1.2

EPIDE

674 ×1.2

653 ×1.2

451 ×0.9

BIOCH

507 ×1.4

PHYSI

Citations per year, relative to Marta López‐Parra Marta López‐Parra (= 1×) peers Eva Morán‐Salvador

Countries citing papers authored by Marta López‐Parra

Since Specialization

Citations

This map shows the geographic impact of Marta López‐Parra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta López‐Parra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta López‐Parra more than expected).

Fields of papers citing papers by Marta López‐Parra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta López‐Parra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta López‐Parra. The network helps show where Marta López‐Parra may publish in the future.

Co-authorship network of co-authors of Marta López‐Parra

This figure shows the co-authorship network connecting the top 25 collaborators of Marta López‐Parra. A scholar is included among the top collaborators of Marta López‐Parra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta López‐Parra. Marta López‐Parra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morán‐Salvador, Eva, Marta López‐Parra, Verónica García‐Alonso, et al.. (2011). Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts. The FASEB Journal. 25(8). 2538–2550. 333 indexed citations

Horrillo, Raquel, Ana González‐Périz, Marcos Martínez‐Clemente, et al.. (2010). 5-Lipoxygenase Activating Protein Signals Adipose Tissue Inflammation and Lipid Dysfunction in Experimental Obesity. The Journal of Immunology. 184(7). 3978–3987. 129 indexed citations

Titos, Esther, Natàlia Ferré, Juan José Lozano, et al.. (2010). Protection from hepatic lipid accumulation and inflammation by genetic ablation of 5-lipoxygenase. Prostaglandins & Other Lipid Mediators. 92(1-4). 54–61. 21 indexed citations

Morán‐Salvador, Eva, Marta López‐Parra, Esther Titos, et al.. (2010). 80 ROLE FOR PPAR γ IN HEPATIC STEATOSIS AS DETERMINED BY HEPATOCYTE AND KUPFFER CELL-SPECIFIC CONDITIONAL KNOCKOUTS USING CRE RECOMBINASE. Journal of Hepatology. 52. S36–S37. 9 indexed citations

Martínez‐Clemente, Marcos, Natàlia Ferré, Ana González‐Périz, et al.. (2009). 5-Lipoxygenase Deficiency Reduces Hepatic Inflammation and Tumor Necrosis Factor α–Induced Hepatocyte Damage in Hyperlipidemia-Prone Apoe-Null Mice. Hepatology. 51(3). 817–827. 90 indexed citations

Ferré, Natàlia, Marcos Martínez‐Clemente, Marta López‐Parra, et al.. (2009). Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols. American Journal of Physiology-Gastrointestinal and Liver Physiology. 296(3). G553–G562. 64 indexed citations

González‐Périz, Ana, Raquel Horrillo, Natàlia Ferré, et al.. (2009). Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins. The FASEB Journal. 23(6). 1946–1957. 475 indexed citations

López‐Parra, Marta, Esther Titos, Raquel Horrillo, et al.. (2008). Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice. Journal of Lipid Research. 49(12). 2513–2523. 45 indexed citations

Horrillo, Raquel, Anna Planagumà, Ana González‐Périz, et al.. (2007). Comparative Protection against Liver Inflammation and Fibrosis by a Selective Cyclooxygenase-2 Inhibitor and a Nonredox-Type 5-Lipoxygenase Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 323(3). 778–786. 48 indexed citations

10.

López‐Parra, Marta, Esther Titos, Anna Planagumà, et al.. (2006). Gene expression profiling of renal dysfunction in rats with experimental cirrhosis. Journal of Hepatology. 45(2). 221–229. 3 indexed citations

11.

Titos, Esther, Joan Clària, Anna Planagumà, et al.. (2005). Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells. Journal of Leukocyte Biology. 78(4). 871–878. 51 indexed citations

12.

Clària, Joan, Jeffrey D. Kent, Marta López‐Parra, et al.. (2005). Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites†. Hepatology. 41(3). 579–587. 58 indexed citations

13.

Planagumà, Anna, Joan Clària, Rosa Miquel, et al.. (2005). The selective cyclooxygenase‐2 inhibitor SC‐236 reduces liver fibrosis by mechanisms involving non‐parenchymal cell apoptosis and PPARγ activation. The FASEB Journal. 19(9). 1120–1122. 114 indexed citations

14.

Clària, Joan & Marta López‐Parra. (2005). New Perspectives in the Modulation of the Eicosanoid Cascade in Inflammation. Letters in Drug Design & Discovery. 2(5). 391–402. 3 indexed citations

15.

López‐Parra, Marta, Joan Clària, Esther Titos, et al.. (2004). The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARγ. Influence of albumin. Journal of Hepatology. 42(1). 75–81. 17 indexed citations

16.

Planagumà, Anna, Joan Clària, Marta López‐Parra, et al.. (2004). 21 The selective cyclooxygenase-2 inhibitor SC-236 reduces experimental liver fibrosis by inactivating kupffer cells and acting as a peroxisome proliferator-activated receptor gamma ligand. Journal of Hepatology. 40. 8–9. 1 indexed citations

17.

Titos, Esther, Joan Clària, Anna Planagumà, et al.. (2003). Inhibition of 5‐lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis. The FASEB Journal. 17(12). 1745–1747. 65 indexed citations

18.

López‐Parra, Marta, Joan Clària, Anna Planagumà, et al.. (2002). Cyclooxygenase‐1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites. British Journal of Pharmacology. 135(4). 891–900. 35 indexed citations

19.

Planagumà, Anna, Esther Titos, Marta López‐Parra, et al.. (2002). Aspirin (ASA) regulates 5‐lipoxygenase activity and peroxisome proliferator‐activated receptor α‐mediated CINC‐1 release in rat liver cells: novel actions of lipoxin A ₄ (LXA ₄ ) and ASA‐triggered 15‐epi‐LXA ₄. The FASEB Journal. 16(14). 1937–1939. 45 indexed citations

20.

Titos, Esther, Joan Clària, Anna Planagumà, et al.. (2002). 5-lipoxygenase (5-LO) is involved in Kupffer cell survival. Journal of Hepatology. 36. 75–75. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact